Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete
NCT ID: NCT06995768
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2025-04-22
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Training in Female Youth Soccer
NCT06136299
Effect of Neck Training on Outcomes Related to Sport-Related Concussion
NCT06774976
Effects of Hypoxic Repeated Sprint Training on Performance in Normoxia in Male and Female Athletes
NCT05439239
Using Energy Availability as a Strategy to Explore the Effects of Relative Energy Deficiency in Sport on Athletes
NCT05649267
Recovery Optimization Intervention to Reduce the Risk of Injuries in Soccer Players
NCT06920966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary outcomes are pre-exercise hydration status measured by urine specific gravity (USG) and estimation of menstrual cycle phase collected by self-report date of last menstrual cycle.
Athletes will complete a single day of testing, unless a repeat test is requested by the team's performance staff. In this case, athletes will undergo the exact same protocol as described above.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Female team sports athletes aged 13 and over
Multiple athletic teams at locations in USA and UK
Sweat patch
Wear sweat patch during regular team sports practice session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sweat patch
Wear sweat patch during regular team sports practice session
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is 13yrs+
* Subject has been cleared for sport participation by their personal or team physician and/or coach-led practice/training.
* Subject is participating in sport on the youth/ amateur/ collegiate/professional/elite level
* If under 18, a parental/guardian consent form will be completed.
Exclusion Criteria
* Subject has an allergy to adhesives (e.g., experiences rash reactions to typical adhesive bandages
13 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PepsiCo Global R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Randell, PhD
Role: PRINCIPAL_INVESTIGATOR
PepsiCo R&D Life Sciences, Sports Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gatorade Sports Science Institute
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEP-2506
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.